Lombardi Comprehensive Cancer Center at Georgetown University Medical Center
3970 Reservoir Rd NW E501
Washington, District of Columbia 20007
(202) 687-2110 http://lombardi.georgetown.edu

Use our guide to learn which trials are right for you!

Georgetown Lombardi Comprehensive Cancer Center, part of Georgetown University Medical Center and MedStar Georgetown University Hospital, seeks to prevent, treat, and cure cancers by linking scientific discovery, expert and compassionate patient care, quality education, and partnership with the community; guided by the principle of cura personalis, "care for the whole person."

Lombardi is one of only 41 comprehensive cancer centers in the nation, as designated by the National Cancer Institute (NCI), and the only one in the Washington, DC, area. The director of the Cancer Center is Louis M. Weiner, MD.

Established in 1970, the Georgetown Lombardi Comprehensive Cancer Center is named for legendary football coach Vince Lombardi, who was treated for cancer at Georgetown University Hospital. What began as a small clinic treating cancer patients has grown into a state-of-the-art cancer center housing more than 240,000 square feet of clinic and research space.

In 1974, Georgetown Lombardi became the 16th NCI-designated Comprehensive Cancer Center in the country. Today, we remain the only center with this designation in the Washington, DC, area, and one of just 41 in the entire country.

We've found
10 trials
at this facility
Oncology Clinical Trial
Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Status: Enrolling, Phase II
Updated: 10/7/2013
mi
from
Washington DC,
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Auto Transplant High Dose Melphalan vs High Dose Melphalan+Bortezomib in Pts With Multiple Myeloma Age 65 Years or Older
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Washington DC,
Click here to add this to my saved trials
Oncology Clinical Trial
Expressive Helping for Stem Cell Transplant Patients
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Washington DC,
Click here to add this to my saved trials
Oncology Clinical Trial
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Status: Enrolling
Updated: 7/22/2013
mi
from
Washington DC,
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Check Point Inhibition After Autologous Stem Cell Transplantation in Patients at High Risk of Post Transplant Recurrence
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Washington DC,
Click here to add this to my saved trials
Neuroblastoma Clinical Trial
Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma
Status: Enrolling
Updated: 4/5/2011
mi
from
Washington DC,
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling, Phase II
Updated: 12/6/2012
mi
from
Washington DC,
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Magnetic Resonance Imaging in Women Receiving Chemotherapy for Stage III Breast Cancer
Status: Enrolling
Updated: 4/10/2010
mi
from
Washington DC,
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling, Phase II
Updated: 3/15/2011
mi
from
Washington DC,
Click here to add this to my saved trials
Colorectal Cancer Clinical Trial
Bispecific Antibody in Finding Tumor Cells in Patients With Colorectal Cancer
Status: Enrolling, Phase I
Updated: 9/16/2013
mi
from
Washington DC,
Click here to add this to my saved trials